AMPK can inhibit Ang II induced-cell proliferation through affecting the extracellular signaling regulatory system (109), suggesting that AMPK may be a drug target for treating heart failure, especially myocardial fibrosis. The gene discussed is PRKAA2; the disease is Myocardial fibrosis.